Imagia Partners with Illumina to Scale Discoveries Across Genomic and Clinical Data

MONTRÉAL, June 22, 2020 /CNW Telbec/ –  Imagia, a leading healthcare AI company that unites healthcare expertise and advanced artificial intelligence technology, and Illumina, a global leader in DNA sequencing and analysis, today announced a partnership to investigate how genomics, clinical data and imaging will enable precision medicine, facilitating therapeutic selection and improve patient outcomes.